RenovoRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-8.05	-10.23	-9.89	-6.32	-3.8	-3.84
Depreciation & Amortization	0	0	0.01	0.01	0	0
Share-Based Compensation	1.14	1.08	0.64	0.15	0.03	0.04
Other Operating Activities	-2.85	-1.1	0.43	0.25	0.24	0.45
Operating Cash Flow	-9.76	-10.26	-8.81	-5.92	-3.53	-3.35
Capital Expenditures	0	0	0	-0.02	0	0
Change in Investments	0	2.03	-2.03	0	0	-0
Investing Cash Flow	0	2.03	-2.03	-0.02	0	-0
Share Issuance / Repurchase	10.42	5.01	0.04	17.35	0.02	0
Debt Issued / Paid	0	0	0	1.98	3.16	0
Other Financing Activities	-	-	-	-	0.03	-
Financing Cash Flow	10.42	5.01	0.04	19.33	3.2	0
Net Cash Flow	0.67	-3.22	-10.8	13.4	-0.33	-3.35
Free Cash Flow	-9.76	-10.26	-8.81	-5.93	-3.53	-3.35
Free Cash Flow Per Share	-0.65	-1.00	-0.97	-1.14	-1.59	-1.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).